Cost-effectiveness of remdesivir and dexamethasone for COVID-19 treatment in South Africa

<p><strong> Background</strong></p> Dexamethasone and remdesivir have the potential to reduce coronavirus disease 2019 (COVID)–related mortality or recovery time, but their cost-effectiveness in countries with limited intensive care resources is unknown. <p><strong&...

詳細記述

書誌詳細
主要な著者: Jo, Y, Jamieson, L, Edoka, I, Long, L, Silal, S, Pulliam, JRC, Moultrie, H, Sanne, I, Meyer-Rath, G, Nichols, BE
フォーマット: Journal article
言語:English
出版事項: Oxford University Press 2021